{"id":"propylene-glycol-0-6","safety":{"commonSideEffects":[{"rate":null,"effect":"Contact dermatitis or skin irritation"},{"rate":null,"effect":"Allergic sensitization (rare)"}]},"_chembl":{"chemblId":"CHEMBL286398","moleculeType":"Small molecule","molecularWeight":"76.10"},"_dailymed":{"setId":"b2c2fd0f-b944-6b0b-e053-2995a90aa216","title":"VISTA MEIBO TEARS PROPYLENE GLYCOL 0.6% W/V ADVANCED DRY EYE RELIEF LUBRICATING DROPS 10 ML (PROPYLENE GLYCOL) LIQUID [RED WEDDING LLC]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Propylene glycol is a small organic compound that functions primarily as a hygroscopic agent, attracting and retaining water in the stratum corneum and other tissues. It also serves as a penetration enhancer and preservative in topical formulations. At 0.6% concentration, it provides moisturizing and stabilizing effects in pharmaceutical preparations.","oneSentence":"Propylene glycol acts as a humectant and solvent that draws moisture into tissues and helps maintain hydration of the skin or mucous membranes.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:03:05.471Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Topical moisturizing agent in ophthalmic or dermatological formulations"}]},"trialDetails":[{"nctId":"NCT07451184","phase":"PHASE4","title":"Comparison of Ocular Lubricants in People With Symptoms of Dry Eye","status":"RECRUITING","sponsor":"University of Waterloo","startDate":"2026-02-23","conditions":"Dry Eye Symptoms","enrollment":100},{"nctId":"NCT06770491","phase":"PHASE1","title":"A Phase 1 Study of Y-3 in US Healthy Volunteers.","status":"COMPLETED","sponsor":"Neurodawn Pharmaceutical Co., Ltd.","startDate":"2025-02-04","conditions":"Safety, Tolerability, Pharmacokinetic Study in Healthy Volunteers","enrollment":20},{"nctId":"NCT04111965","phase":"PHASE1, PHASE2","title":"Clinical Trial to Compare the Safety and Efficacy of Nanodrop®","status":"COMPLETED","sponsor":"Laboratorios Sophia S.A de C.V.","startDate":"2020-12-01","conditions":"Dry Eye","enrollment":126},{"nctId":"NCT07055412","phase":"PHASE1","title":"Y-3 for Injection in Patients With Hepatic Insufficiency and Healthy Subjects","status":"NOT_YET_RECRUITING","sponsor":"Neurodawn Pharmaceutical Co., Ltd.","startDate":"2025-07-10","conditions":"Pharmacokinetic Differences, Y-3, Saftey","enrollment":24},{"nctId":"NCT06188260","phase":"PHASE2","title":"Efficacy of a New Nanoemulsion Artificial Tear Targeting Dry Eye Disease","status":"COMPLETED","sponsor":"The Hong Kong Polytechnic University","startDate":"2024-01-16","conditions":"Dry Eye Syndromes","enrollment":31},{"nctId":"NCT05056155","phase":"NA","title":"Systane Complete Multi-symptom Relief","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2021-11-09","conditions":"Dry Eye Disease","enrollment":119},{"nctId":"NCT03279731","phase":"PHASE3","title":"Binge Eating Liraglutide Intervention","status":"TERMINATED","sponsor":"Kelly Allison","startDate":"2017-09-29","conditions":"Binge-Eating Disorder","enrollment":36},{"nctId":"NCT02776670","phase":"NA","title":"Clinical Outcomes Following Treatment With SYSTANE® BALANCE","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2016-07-29","conditions":"Dry Eye","enrollment":308},{"nctId":"NCT03706443","phase":"NA","title":"Tear Lipid Layer Thickness Changes With Use of Emollient and Non-Emollient Eye Drops","status":"COMPLETED","sponsor":"Ohio State University","startDate":"2018-12-05","conditions":"Dry Eye Syndromes, Keratoconjunctivitis Sicca, Lacrimal Apparatus Diseases","enrollment":24},{"nctId":"NCT03936712","phase":"NA","title":"Effect of Energy Drink on Sport Performance and Psycho-Physiological Responses.","status":"COMPLETED","sponsor":"The Higher Institute of Sport and Physical Education of Sfax","startDate":"2017-01-01","conditions":"Physical Activity","enrollment":22},{"nctId":"NCT02511379","phase":"NA","title":"Clinical Evaluation of Systane® Balance in Dry Eye Subjects","status":"TERMINATED","sponsor":"Alcon Research","startDate":"2015-11-26","conditions":"Dry Eye","enrollment":14},{"nctId":"NCT02956083","phase":"NA","title":"The Effect of Tear Supplements on Contact Lens Comfort","status":"COMPLETED","sponsor":"University of the Incarnate Word","startDate":"2014-07","conditions":"Dry Eye Syndromes, Meibomian Gland Dysfunction","enrollment":30},{"nctId":"NCT01967147","phase":"NA","title":"Clinical Outcomes Following Treatment With Systane® Balance in Dry Eye Subjects","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2014-02","conditions":"Dry Eye","enrollment":279},{"nctId":"NCT01718028","phase":"NA","title":"The Effect of SYSTANE® BALANCE on Tear Film Break Up Time in Dry Eye Subjects","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2012-09","conditions":"Dry Eye","enrollment":51},{"nctId":"NCT01451905","phase":"NA","title":"GLP-1 Receptors in Normal Skin and Skin From Patients With Psoriasis","status":"UNKNOWN","sponsor":"University Hospital, Gentofte, Copenhagen","startDate":"2011-08","conditions":"Reduction of Psoriasis Following Liraglutide Therapy in Terms of PASI and DLQI","enrollment":12}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":102,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Propylene glycol 0.6%","genericName":"Propylene glycol 0.6%","companyName":"University of Waterloo","companyId":"university-of-waterloo","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Propylene glycol acts as a humectant and solvent that draws moisture into tissues and helps maintain hydration of the skin or mucous membranes. Used for Topical moisturizing agent in ophthalmic or dermatological formulations.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}